Tag Archives: Johnson & Johnson

Adena Health/Ross Health District Offering COVID Shot At Ross County Fair

Presented By Classic Brands

(CHILLICOTHE) – The best defense against the spread of COVID-19 in our communities is vaccination. With the return of a full slate of Ross County Fair activities this week and the accompanying crowds following a one-year hiatus in 2020 because of the virus, having convenient access to that defense is important.

Toward that end, Adena Health System and the Ross County Health District are partnering to make free vaccinations available to fairgoers. Adena is administrating the one dose Johnson & Johnson COVID-19 vaccine for those 18 and older from 4 to 8 p.m. Monday (August 9), Wednesday (August 11) and Friday (August 13), at a booth in the northwest corner of the Multipurpose Building at the Ross County Fairgrounds. For parents wishing to have their children ages 12 to 17 vaccinated, the Ross County Health District will be administrating the Pfizer vaccine to that age range from 12 to 4 p.m. on Tuesday (August 10) and Thursday (August 12).

With the recent surge of the Delta variant of COVID-19 spreading across the country, Adena and the Ross County Health District want to make sure getting the vaccine is as convenient as possible – part of the important role each organization plays in caring for the health of our communities. The trio of available COVID-19 vaccines have proven effective against the virus, including the Delta variant, in reducing serious illness, hospitalizations and deaths.

So while you’re enjoying the fair food, entertainment and 4-H competition at the 2021 Ross County Fair, we encourage you to take a few minutes to stop by the Multipurpose Building and take that key step in protecting your health that will last long after the final midway ride has been taken. Also remember to wash your hands frequently and maintain social distancing as much as possible as you enjoy the week.

J&J Vaccine Reopen For Receiving in Ohio

Presented By Hometown-Motors, Inc.

(COLUMBUS)—Following the recommendation from the CDC’s Advisory Committee on Immunization (ACIP) that the use of Johnson & Johnson vaccine resume in the U.S., Governor Mike DeWine has released the following statement:

“Our country’s vaccine safety system has worked as designed – these extremely rare, serious blood-clotting events were reported into the CDC’s Vaccine Adverse Event Reporting System (VAERS), and the vaccine distribution was paused to allow a thorough review of the facts and time to educate healthcare providers on the rare events. Now, a comprehensive analysis by the independent medical professionals on the ACIP has resulted in the recommendation that the benefits of Johnson & Johnson vaccine outweigh the risks, and that vaccine administration resume. The CDC and FDA have accepted those recommendations, lifting the pause on the Johnson & Johnson COVID-19 vaccine. Providers in Ohio are permitted to immediately resume administering Johnson & Johnson vaccines in Ohio, provided they continue to follow all guidance by the CDC and FDA.”

The Ohio Department of Health is issuing guidance to providers to ensure they have access to the latest information on the use of Johnson & Johnson vaccines, and that healthcare providers are aware of treatment methods for these extremely rare but potentially life-threatening cases of thrombosis with thrombocytopenia syndrome (TTS).

According to the FDA, people who have received the Johnson & Johnson COVID-19 vaccine and develop shortness of breath, chest pain, leg swelling, persistent abdominal pain, neurological symptoms (including severe or persistent headaches or blurred vision), or petechiae beyond the site of vaccination should seek immediate medical care.

Additional information on mass vaccination clinics, mobile vaccine strategies, and specific sites resuming Johnson & Johnson are not available at this time. Officials with the Ohio Department of Health will continue to follow this situation closely.

Additional resources from the CDC and FDA:

FDA Pauses Use of Johnson & Johnson COVID-19 Vaccine

Presented By Atomic Speedway

UPDATED 3pm (4/13/21)

(COLUMBUS)—Today (4/13/21) Governor Mike DeWine, Ohio Department of Health Director Stephanie McCloud, and Ohio Department of Health Chief Medical Officer Bruce Vanderhoff, M.D., are advising all Ohio vaccine providers to temporarily pause using the Johnson and Johnson (Janssen) vaccine. 

This is in response to a statement by the Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) recommending a pause in the use of the Johnson and Johnson vaccine following extremely rare blood-clotting events of six people in the U.S. after receiving the vaccine. Those problems occurred within 6-13 days of the six individuals receiving the shot.

Over 200,000 Ohioans have already received the J&J shot, and the Governor says he’s been told by the White House that the pause on using the Johnson & Johnson vaccine will likely be “days instead of weeks.”

The CDC will convene a meeting of the Advisory Committee on Immunization Practices Wednesday to further review these cases.

Officials with the Ohio Department of Health are following this situation closely.

The directive from the FDA and CDC appeared on FDA’s Twitter.

“We are recommending a pause in the use of this vaccine out of an abundance of caution.”

Federal officials say further “As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare. Treatment of this specific type of blood clot is different from the treatment that might typically be administered.”

CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases.

“Until that process is complete, we are recommending this pause. This is important to ensure that the health care provider community is aware of the potential for these adverse events and can plan due to the unique treatment required with this type of blood clot.”

In Ross County, Adena Health System is stopping its Johnson & Johnson COVD-19 vaccines following Food and Drug Administration (FDA), Centers for Disease Control (CDC) and the Ohio Department of Health (ODH) guidance.

Spokeperson Jason Gilham said “We will be continuing our mass vaccination clinic appointments for this week Wednesday through Friday using the Moderna vaccine and scheduling those individuals for their second appointments. Anyone scheduled at the Adena PACCAR Medical Education Center mass vaccination clinic this week will receive a call from ODH regarding the change from Johnson & Johnson to Moderna vaccines with the option if they want to keep their appointment.”

Members of the Ohio National Guard administer Johnson & Johnson COVID-19 vaccination at Adena’s PACCAR Medical Education Center. Photo courtesy Adena Health System